Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The effect of whole-body, repetitive, inhomogeneous static magnetic field-exposure on the symptoms of experimental autoimmune encephalomyelitis in mice.
Contribution of CD8 T lymphocytes to the immuno-pathogenesis of multiple sclerosis and its animal models.
Ischemic colitis with type I interferons used in the treatment of hepatitis C and multiple sclerosis: an evaluation from the food and drug administration adverse event reporting system and review of the literature.
Toll-like receptor-9 in Spanish multiple sclerosis patients: an association with the gender.
What are exosomes and how can they be used in multiple sclerosis therapy?
Multicystic demyelinating myelopathy: Widening spectrum of pediatric aquaporin-4 autoimmunity.
Immunomodulatory effects of adipose-derived mesenchymal stem cells on the gene expression of major transcription factors in T cell subsets.
A GPBAR1 (TGR5) Small Molecule Agonist Shows Specific Inhibitory Effects on Myeloid Cell Activation In Vitro and Reduces Experimental Autoimmune Encephalitis (EAE) In Vivo.
Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
Agent based modeling of the effects of potential treatments over the blood-brain barrier in multiple sclerosis.
Progressive MS: from pathophysiology to drug discovery.
Anti-CD20 antibody wows in multiple sclerosis.
Quantifying brain tissue volume in multiple sclerosis with automated lesion segmentation and filling.
In-silico prediction of drug targets, biological activities, signal pathways and regulating networks of dioscin based on bioinformatics.
Neurobiology: Myelin Goes Where the Action Is.
Single Dose of Glycoengineered Anti-CD19 Antibody (MEDI551) Disrupts Experimental Autoimmune Encephalomyelitis by Inhibiting Pathogenic Adaptive Immune Responses in the Bone Marrow and Spinal Cord While Preserving Peripheral Regulatory Mechanisms.
A multicomponent T2 relaxometry algorithm for myelin water imaging of the brain.
Can we define a rehabilitation strategy for cognitive impairment in progressive multiple sclerosis? A critical appraisal.
Improving drug delivery technology for treating neurodegenerative diseases.
Computerised cognitive training in acquired brain injury: A systematic review of outcomes using the International Classification of Functioning (ICF).
Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
Fatigue heralding multiple sclerosis.
Regional regulation of glutamate signaling during cuprizone-induced demyelination in the brain.
IL-27-induced modulation of autoimmunity and its therapeutic potential.
Sequencing the immunopathologic heterogeneity in multiple sclerosis.

Pages